Sign In  |  Register  |  About San Anselmo  |  Contact Us

San Anselmo, CA
September 01, 2020 1:33pm
7-Day Forecast | Traffic
  • Search Hotels in San Anselmo

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

GCAC and Abbey Technologies CEO Roundtable Discusses the Impact of Cross-Fi



 

Vancouver, British Columbia, Canada – TheNewswire - May 25, 2021 — Global Cannabis Applications Corp. (“GCAC” or the “Company) (CSE:APP), (CNSX:APP.CN), (OTC:FUAPF), (FSE:2FA), a leading developer of innovative data technologies for the medical cannabis industry, today announced that CEO Brad Moore will be joined by Abbey Technologies CEO Brian Collins will discuss Abbey’s innovative new Cross-Fi (Cross-Market Finance) marketing program.  Hailed as the “great equalizer” for young startups by Moore, this 30-minute roundtable discussion will be hosted by the Emerging Growth Conference on May 26, 2021at 1PM EST (10AM PST).

GCAC invites individual and institutional investors, as well as advisors and analysts to attend this real-time, interactive presentation at the Emerging Growth Conference. Please register at https://goto.webcasts.com/starthere.jsp?ei=1465229&tp_key=acb55f1b36&sti=fuapf to attend the conference and receive any updates that are released.

 

Cross-Fi is a revolutionary concept about to take the crypto world by storm. Combining the safety and structure of a publicly listed stock with the decentralized ease and peace of mind of having full control over your funds, Cross-Fi is here to change the game, with the Uniswap GCAC Token pair being the first to ever be released.

This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with both Moore and Collins in real time. The two industry leaders will discuss the details of Cross-Fi, what it is doing for GCAC, why businesses should consider using it, and if time allows, open the floor for questions. Please ask your questions during the event and both participants will do their best to address as many of them as possible.

If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available on EmergingGrowth.com and we will also release a link to the session after the event.

About the Emerging Growth Conference

The Emerging Growth conference is an effective way for public companies to present and communicate their new products, services and other major announcements to the investment community from the convenience of their office, in a time efficient manner. The Conference focus and coverage includes companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long term growth. Its audience includes potentially tens of thousands of Individual and Institutional investors, as well as Investment advisors and analysts.

 

About Abbey Technology GmbH, “Abbey”

Abbey, a Swiss company, specializes in developing, licensing and operating innovative blockchain technologies. The “Public-Company to Uniswap-Token” marketing platform was invented by Abbey alongside its Ethereum layer-2 high-throughput blockchain software-as-a-service. For information on Uniswap-token marketing campaigns for public companies visit https://abbey.ch.

 

About Global Cannabis Applications Corp.
Global Cannabis Applications Corp. is a global leader in designing, developing, SaaS licensing, and acquiring innovative data technologies for the medical cannabis industry. The Citizen Green and Efixii platforms are the world’s first end-to-end — from patient to regulator — medical cannabis data solutions. They use six core technologies: mobile applications, artificial intelligence, RegTech, smart databases, Ethereum blockchain, and GCAC smart rewards. These technologies transparently disclose cannabis chain-of-custody events, thereby enabling patients to provide crowd-sourced medical cannabis efficacy data. Driven by digital and cannabis industry experts, GCAC is focused on generating revenue from licensing its SaaS technology and acquiring high quality cannabis datasets that greatly improve patient outcomes.


For more Company information, please visit www.cannappscorp.com, or review its profiles on www.sedar.com and on the Canadian Securities Exchange’s website www.thecse.com.

 

Press Contact
Phone: +1 (800) 409-5679

Email: info@cannappscorp.com


Forward-Looking Information

This news release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of GCAC. Forward-looking information is based on certain key expectations and assumptions made by the management of GCAC. Although management of the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because GCAC can give no assurance that they will prove to be correct. Forward-looking statements contained in this news release are made as of the date of this news release. GCAC disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

 

The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy and accuracy of this information.

Copyright (c) 2021 TheNewswire - All rights reserved.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 SanAnselmo.com & California Media Partners, LLC. All rights reserved.